We channel resources to the right innovations to co-create a Vegan Utopia.

At Vtopian, we invest in, and help grow, early-stage businesses whose mission seeks to remove animals from the supply chain.

The vegan market opportunity is massive, but it needs more dedicated resources.

 

Mission-Driven Team

Our team is made up of passionate vegans, environmentalists, and sustainability advocates. We believe that in order to make sound impact investments, our team has to be passionate about the change we are seeking to create in the world.

Diverse Career Backgrounds

Our team comprises of professionals working or have worked as management consultants, lawyers, bankers, and investment analysts. This diverse skillset and expertise enables us in sourcing and executing deals that create impact for the world whilst generating compelling returns on investments.

We Grow Together

We’re not just here to invest - we’re here to grow together as partners with our portfolio companies. New ventures can capitalize on our network and expertise to drive organic, sustainable growth.

 

Some of our key target sectors…

Food Is Huge

According to a study from University of Oxford, animal products use about 83% of the world’s farmland, but yield only 18% of total consumed calories. It’s a highly inefficient industry, and there are massive opportunities to disrupt this legacy industry with alternative protein technologies such as plant-based protein, precision fermentation, and cell-based protein.

Ethical Fashion Should Be Normalized

Be it fur, leather, wool, down, or silk, the fashion industry’s use of animals as a byproduct is a laughable myth. The animals used in the fashion industry are bred specifically for the industries, often times the food aspect is actually the byproduct. A whole host of alternative fabrics are available in the market but requires resources to scale up production to drive down costs for mass market adoption.

Animal Research Needs to Go

We’re in this day and age where we send humans into space to travel, yet we are still testing drugs on animals. This is a pure legacy with proven alternative technologies available. It’s a rapidly growing market too - according to a report from Research and Markets, the global non-animal alternative testing market was valued at US$1.11 billion in 2019, and expected to grow at a CAGR of 10.40% during 2019-2025.

 

We invest with our founding partners’ own capital. It’s true skin in the game.

At the moment, we are not raising funds from external investors.